Stock fact sheet · data as of
Nutex Health, Inc. (NUTX): fair value, margin of safety and Wheel Score
Healthcare · Medical - Care Facilities · United States · High Growth
Is NUTX undervalued?
NUTX has a margin of safety of 73%: the stock closed at 200.80 on 16 Oct 2026 against a GLS average fair value of 732.07. 5 of the 7 valuation models that produced a number sit above the price. Our screens treat a discount this large as a strong starting point for a cash-secured put, not as a verdict - the fair value is a model output, and a wide gap can mean the models are missing something the market knows.
There is a wide gap between Lynch (104.74) and GLS Growth (1,603.09). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.
The nightly engine files NUTX under High Growth: revenue and earnings growing fast enough that the growth-based models carry the valuation.
Nine valuation models for NUTX
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | - | - | Present value of the projected free cash flows, discounted at the cost of capital; no value tonight |
| Graham Number | 183.88 | -8% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 422.46 | +110% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 104.74 | -48% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 1,603.09 | +698% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 939.27 | +368% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 1,580.08 | +687% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | 290.95 | +45% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | 6.38 | -97% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 310.00 | +54% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Nutex Health, Inc. scores 6 of 9 on the Piotroski F-score: a middling result that passes the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. On durability NUTX scores 6.5/10 on the GLS Moat - a middle reading; the Scorecard on the Quote page's Financials tab shows which ten-year lines are steady and which are not.
Returns on capital are moderate - ROIC 10.4%, ROE 21.5%, ROA 7.7% - with debt at 1.07 times equity and a free-cash-flow yield of 19.9%.
Nutex Health, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Hospital Division 100% (quarter Q2 FY2026).
Institutional ownership scores 5/10, insider activity 6/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 6 / 9 | ROIC | 10.4% |
|---|---|---|---|
| GLS Moat | 6.5 / 10 | ROE | 21.5% |
| Debt / equity | 1.07 | ROA | 7.7% |
| Free-cash-flow yield | 19.9% | Payout ratio | 29% |
| Institutions | 5 / 10 | Insiders · Congress | 6 · 5 / 10 |
Wheel Score 39: No options
No options are listed on Nutex Health, Inc. in our nightly snapshot. The Wheel Score is therefore capped at 39 (it reads 39) and the stock is left out of every options screen; the fair value and health figures above are still useful for a plain stock position.
Volume runs at 141k shares a day on a market cap of $1.4B, with a beta of 2.02 - a high beta, so the stock tends to move more than the market and a strike can be gapped through; the Stability part of the Wheel Score gives that 7 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 25 / 25 | 73% margin of safety | |
| Health | 13 / 20 | Piotroski 6/9 | |
| Moat | 10 / 15 | moat 6.5/10 | |
| Premium | 0 / 20 | no option data | |
| Stability | 7 / 20 | 141k shares/day, $1.4B cap, beta 2.02 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
The next earnings report is due on 17 Nov 2026, 32 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Care Facilities
The 12 companies below are the closest to Nutex Health, Inc. by market cap within the Medical - Care Facilities industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| PNTG The Pennant Group, Inc. | 40.82 | 26.64 | -53% | 51Fair | $1.4B |
| HCSG Healthcare Services Group, Inc. | 21.43 | 45.20 | +53% | 82Prime | $1.5B |
| AGL Agilon Health, Inc. | 88.45 | - | - | 37Weak | $1.5B |
| USPH U.S. Physical Therapy, Inc. | 84.91 | 50.56 | -68% | 45Weak | $1.3B |
| INNV Innovage Holding Corp. | 8.98 | 8.21 | -9% | 45Weak | $1.2B |
| AMN AMN Healthcare Services, Inc. | 40.00 | 75.98 | +47% | 81Prime | $1.5B |
| SNDA Sonida Senior Living, Inc. | 35.79 | 112.02 | +68% | 45Weak | $1.7B |
| ARDT Ardent Health Inc. | 12.20 | 28.12 | +57% | 80Prime | $1.7B |
| ASTH Astrana Health, Inc. | 38.03 | 37.22 | -2% | 55Fair | $1.9B |
| SGRY Surgery Partners, Inc. | 14.83 | 46.26 | +68% | 45Weak | $1.9B |
| ADUS Addus HomeCare Corporation | 116.49 | 115.55 | -1% | 67Good | $2.2B |
| MD Pediatrix Medical Group, Inc. | 27.76 | 34.92 | +21% | 78Good | $2.3B |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about NUTX
Is NUTX undervalued right now?
By the GLS models, yes: at 200.80 the stock is 73% below the average fair value of 732.07 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.
What is the Wheel Score of NUTX and what does it mean?
NUTX has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".
What is the GLS fair value for NUTX?
732.07 per share as of 16 Oct 2026 - the simple average of the 7 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does Nutex Health, Inc. report earnings next?
The next earnings report is due on 17 Nov 2026, 32 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.
Does NUTX have listed options, and how liquid are they?
No. The nightly options snapshot found no listed contracts on NUTX, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.